论文部分内容阅读
阿克拉霉素(Aclacinomycin,简称ACM)是一种新的蒽环族抗肿瘤抗生素,1975年由日本Oki等发现。1988年7月至1989年底我们采用了国产ACM(四川抗生素工业研究所提供)治疗急性白血病(AL),现将结果报告如下。材料和方法一、病例选择本组53例AL病例均经临床、血常规、骨髓象及细胞化学检查确诊,并按国际FAB协作组标准分型。其中ACM单药化疗者(单用组)
Aclacinomycin (Aclacinomycin, referred to as ACM) is a new anthracycline anti-tumor antibiotics, discovered in Japan by Oki in 1975. July 1988 to the end of 1989 we have adopted a domestic ACM (Sichuan Institute of Antibiotics) treatment of acute leukemia (AL), the results are reported as follows. Materials and methods First, the case selection 53 cases of AL in this group were clinically, blood tests, bone marrow and cytochemical examination confirmed by FAB collaboration group standard international classification. One ACM monotherapy (single use group)